fusion construct (Adamed Pharma)

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug Namefusion construct (Adamed Pharma)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPoland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAdamed Pharma Sa
China Registration ClassN/A

Develop Information

Active CompaniesAdamed Pharma Sa
Inactive CompaniesN/A
Active IndicationsLung Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A